Sj. Connor et al., APPENDICEAL TUMORS - RETROSPECTIVE CLINICOPATHOLOGICAL ANALYSIS OF APPENDICEAL TUMORS FROM 7,970 APPENDECTOMIES, Diseases of the colon & rectum, 41(1), 1998, pp. 75-80
BACKGROUND: Appendiceal tumors are rare and often unexpectedly discove
red in an acute situation, in which decision-making is difficult. To h
elp define the most appropriate management, a retrospective analysis w
as undertaken to describe the clinicopathologic behavior of appendicea
l tumors, and the literature was reviewed of the management of the dif
ferent types of appendiceal tumors. METHOD: From a single center, a hi
stopathologic database of 7,970 appendectomies, all appendiceal tumors
, were identified and case notes reviewed. Analysis of clinical presen
tation, histopathology, operation, and outcome is presented. RESULTS:
During a 16-year period (7,970 appendectomies), 74 patients (0.9 perce
nt) with appendiceal tumors were identified: 42 carcinoid, 12 benign,
and 20 malignant. Acute appendicitis was the most common presentation
(49 percent), and 9.5 percent were incidental findings. Primary malign
ant tumors of the appendix were found in 0.1 percent of all appendecto
mies. Secondary malignant disease was identified in the appendix of 11
patients, most commonly (55 percent) from patients with primary color
ectal disease. There was a high incidence of synchronous and metachron
ous colorectal cancer in all appendiceal tumors: carcinoids, 10 percen
t; benign tumors, 33 percent; secondary malignancies, 55 percent; prim
ary malignancies, 89 percent. CONCLUSION: Appendiceal tumors are uncom
mon and most often present as appendicitis. Most are benign and can be
managed by appendectomy, except adenocarcinomas and carcinoids larger
than 2 cm, which are most appropriately managed by right hemicolectom
y. A suggested management algorithm is provided. Controversy exists ov
er the management of carcinoids 1 to 2 cm in size and adenocarcinoids.
All types of appendiceal tumors have a high incidence of synchronous
and metachronous colorectal cancer.